BACKGROUND: Early detection of maladaptive processes underlying pregnancy-related pathologies is desirable because it will enable targeted interventions ahead of clinical manifestations. The quantitative analysis of plasma proteins features prominently among molecular approaches used to detect deviations from normal pregnancy. However, derivation of proteomic signatures sufficiently predictive of pregnancy-related outcomes has been challenging. An important obstacle hindering such efforts were limitations in assay technology, which prevented the broad examination of the plasma proteome. OBJECTIVE: The recent availability of a highly multiplexed platform affording the simultaneous measurement of 1310 plasma proteins opens the door for a more explorative approach. The major aim of this study was to examine whether analysis of plasma collected during gestation of term pregnancy would allow identifying a set of proteins that tightly track gestational age. Establishing precisely timed plasma proteomic changes during term pregnancy is a critical step in identifying deviations from regular patterns caused by fetal and maternal maladaptations. A second aim was to gain insight into functional attributes of identified proteins and link such attributes to relevant immunological changes. STUDY DESIGN: Pregnant women participated in this longitudinal study. In 2 subsequent sets of 21 (training cohort) and 10 (validation cohort) women, specific blood specimens were collected during the first (7e14 weeks), second (15e20 weeks), and third (24e32 weeks) trimesters and 6 weeks postpartum for analysis with a highly multiplexed aptamer-based platform. An elastic net algorithm was applied to infer a proteomic model predicting gestational age. A bootstrapping procedure and piecewise regression analysis was used to extract the minimum number of proteins required for predicting gestational age without compromising predictive power. Gene ontology analysis was applied to infer enrichment of molecular functions among proteins included in the proteomic model. Changes in abundance of proteins with such functions were linked to immune features predictive of gestational age at the time of sampling in pregnancies delivering at term. RESULTS: An independently validated model consisting of 74 proteins strongly predicted gestational age (P ¼ 3.8 Â 10 e14 , R ¼ 0.97). The model could be reduced to 8 proteins without losing its predictive power (P ¼ 1.7 Â 10 e3 , R ¼ 0.91). The 3 top ranked proteins were glypican 3, chorionic somatomammotropin hormone, and granulins. Proteins activating the Janus kinase and signal transducer and activator of transcription pathway were enriched in the proteomic model, chorionic somatomammotropin hormone being the top-ranked protein. Abundance of chorionic somatomammotropin hormone strongly correlated with signal transducer and activator of transcription-5 signaling activity in CD4 T cells, the endogenous cell-signaling event most predictive of gestational age. CONCLUSION: Results indicate that precisely timed changes in the plasma proteome during term pregnancy mirror a proteomic clock. Importantly, the combined use of several plasma proteins was required for accurate prediction. The exciting promise of such a clock is that deviations from its regular chronological profile may assist in the early diagnoses of pregnancy-related pathologies, and point to underlying pathophysiology. Functional analysis of the proteomic model generated the novel hypothesis that chrionic somatomammotropin hormone may critically regulate T-cell function during pregnancy.
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I
ntricate and timely hormonal, immunological, metabolic, and physiological adaptations during pregnancy are critical for maternal health, normal fetal development, and term delivery.
Maladaptations underlie pregnancy-related pathologies, which include intrauterine growth retardation (IUGR), preeclampsia, and preterm birth. [1] [2] [3] [4] [5] [6] Early detection of maladaptive processes is highly desirable because it will critically enable targeted interventions before clinical manifestations become apparent.
The quantitative analysis of plasma proteins features prominently among molecular approaches used to detect deviations from normal pregnancy and fetal development. While such approaches yielded clinical assays that are particularly useful for the early diagnosis of pregnancy, derivation of proteomic signatures sufficiently predictive of pregnancy-related outcomes has been more challenging. [7] [8] [9] [10] [11] [12] [13] An important obstacle hindering such efforts was limitations in assay technology, which prevented broad examination of the vast plasma proteome. 14 Recent availability of a highly multiplexed platform affording the simultaneous measurement of 1310 plasma proteins opens the door for a more explorative approach. 15, 16 A highly noted recent study using this platform in patients with stable coronary heart disease validated a protein-based risk score including 9 proteins to predict future cardiovascular events. 17 Romero et al 18 used the same platform quite recently to study the abundance of plasma proteins over the course of pregnancy. The investigators found wide-ranging correlative changes and pointed to the potential utility of this approach for detecting disruptive proteomic patterns characterizing pregnancy-related maladaptations. 18 Romero et al 18 reported that 112 proteins significantly changed in abundance during pregnancy. However, the predictive value of reported changes remains uncertain. A critical next step is to determine whether and which of the reported proteomic changes possess predictive value.
The primary aim of this study was to derive and validate a predictive proteomic model using a multivariate approach well suited to extract a concise set of predictive features from modular and highly interrelated data sets. 19 From a practical perspective, we were interested to learn whether a small set of proteins would suffice to predict gestational age at the time of sampling. Positive findings would provide a solid rational to pursue outlined approach for developing proteomic tests to assist the diagnosis of pregnancy-related pathologies.
We were further interested to extract a small set of proteins based on their combined predictive power for further examination. The assumption that these proteins track important physiological adaptations during pregnancy seems reasonable.
A final aim was to link proteins included in the predictive model to immune changes that we previously reported in the same patient cohort to infer novel hypotheses. 19 
Materials and Methods

Study design
Pregnant women presenting to the obstetrical clinics of the Lucile Packard Children's Hospital at Stanford University (Stanford, CA) for prenatal care were invited to participate in a cohort study sponsored by the March of Dimes Prematurity Research Center to prospectively examine an array of environmental and biological factors associated with normal and pathological pregnancies. 20, 21 Women were eligible if they were at least 18 years of age and in their first trimester of singleton pregnancy. Blood samples were obtained during the first (7e14 weeks), second (15e20 weeks), and third (24e32 weeks) trimesters of pregnancy and 6 weeks postpartum.
In 2 subsequent sets of 21 (training cohort) and 10 women (validation cohort), specific blood specimens were collected between August 2014 and March 2015 for detailed proteomic and cellular analyses.
The study was approved by the Institutional Review Board of Stanford University School of Medicine, and all participants provided written informed consent.
Gestational age (GA)
GA was determined by best obstetrical estimate as recommended by the American College of Obstetricians and Gynecologists.
Proteomic assays
A first analysis was performed in the Human Immune Monitoring Center at Stanford University using a standard, human, 62-plex kit from eBiosciences/ Affymetrix (San Diego, CA) according to the manufacturer's recommendations. The assay uses antibody-based sandwich technology to quantify proteins (Appendix A).
A second analysis on the same samples was performed by SomaLogic, Inc (Boulder, CO) using a highly multiplexed, aptamer-based platform capturing 1310 proteins. 15, 16 The assay uses chemically modified aptamers, unique and single-strand DNA segments, which bind with high affinity to specific proteins (Appendix A).
Derivation and validation of a proteomic model predicting GA Derivation and validation of the model used proteomic data collected during pregnancy but did not include proteomic data collected after pregnancy. An elastic net (EN) algorithm using 2 penalization terms, and a crossvalidation approach was used for multivariate analysis. 19, 23, 24 Validation of the proteomic model derived in the training cohort was performed in an independent cohort of women using fixed-model parameters (Appendix A) to determine whether the derived model could predict gestational age in blinded samples.
Reduction of proteomic model
A bootstrapping procedure and piecewise regression was used to reduce the number of model parameters until the power of the model for predicting GA sharply declined (Appendix A). 19 Model reduction is a data-driven approach to select a limited set of nonredundant parameters for further examination and discussion.
Correlation network
Derivation of the correlational network included proteomic data collected during and after pregnancy because its main purpose was to determine which proteins increase and decrease together. Spearman correlation analyses were performed between all pairs of proteins.
The graphical representation of the correlation network shows edges for significant correlations between 2 respective proteins (P < .05; Bonferroni adjustment). The graphical layout was calculated using the t-SNE algorithm.
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To visualize the modularity of the correlation network and emphasize groups of highly interrelated proteins, a preset number of 10 modules was calculated using the K-means algorithm applied to the entire correlation matrix.
Data visualization
Derivation of splines served only visualization purposes and was not part of Original Research OBSTETRICS ajog.org model development and statistical analysis. Individual and population plasma profiles of proteins included in the proteomic model were visualized using smoothing splines. 26 The population profiles and 95% confidence intervals were inferred separately for women included in the training and validation cohorts.
Gene ontology (GO) enrichment analysis
GO terms define gene product properties in the 3 domains: cellular component, molecular function, and biological process. The GO enrichment analysis was performed to create a short list of GO terms that are overrepresented when comparing top-ranked gene products included in the EN model (n ¼ 74) to the complement set of gene products contained on the SomaLogic proteomic platform but not included in the model (n ¼ 1226).
Gene symbols for respective proteins were provided by SomaLogic, Inc. Plasma proteins included in the EN model were ranked according to their correlation coefficients (highest to lowest). GO analysis was performed with the topGO R package. 27 A value of P < .01 not adjusted for multiple comparisons was used for this exploratory analysis.
Linking results of GO enrichment analyses to immune features predictive of GA Spearman's rank correlation was performed to relate proteins associated with enriched GO terms to immune features included in a recently published predictive model of GA. 19 This model, termed an immune clock of pregnancy, was derived from the same population of women reported here.
Briefly, a 33 antibody panel was used to extract 984 immune features including the abundance of 24 major immune cell subtypes, their endogenous signaling activity, and their capacity to respond to a series of receptor-specific ligands including lipopolysaccharide, interferon-a2A, and a mix of interleukins 2 and 6. An EN algorithm identified a validated model containing 25 immune features. The median profile of each cell subtype was used for the correlation analysis.
Results
Study subjects
Seventeen of 21 women in the training cohort and all 10 women in the validation cohort were included in the final analysis. Four women were excluded: 3 delivered preterm (<37 weeks GA), and 1 suffered from severe preeclampsia. Patient and pregnancy characteristics are summarized in Table 1 . Medical history was relevant for well-controlled chronic arterial hypertension (n ¼ 2), asthma (n ¼ 7), and hypothyroidism (n ¼ 1).
Gestational age
All women of the training cohort had ultrasound examinations during the first trimester of pregnancy. According to the guidelines of the American College of Obstetricians and Gynecologists, GA was determined based on standard ultrasound metrics. 22 All but 1 woman of the validation cohort had ultrasound examinations during the first trimester. One woman had her first ultrasound examination during the second trimester (gestational week 18 6/7). In accordance with current guidelines, the date of her last menstrual period was used to determine GA.
This estimate did not need correction when considering second-trimester ultrasound results. Importantly, all women of the training cohort used to derive the proteomic model had GA determined by first-trimester ultrasound results.
Proteomic assays
One hundred ten of 7316 readouts from the 62-plex antibody-based proteomic assay (1.5%) were excluded because of a bead count <50, and 46 readouts (0.6%) were excluded because of a coefficient of variation (CV) >30%. ajog.org
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The median CV of analytes included in the analysis was 3.3% (1.5e6.2; interquartile range). Three of the 81 plasma samples and 10 of the 1310 SOMAmer reagents failed quality-control criteria for the aptamerbased proteomic assay and were excluded from the final analysis. The median CV for SOMAmer reagents was 3.1% (2.1e4.5; interquartile range).
Proteomic platform performance for derivation of the EN model
The model inferred from the 62-plex antibody-based proteomic data set for the training cohort (P ¼ 2.2 Â 10 e4 ) did not pass validation (P ¼ 6.2 Â 10 e2 ) in the independent patient cohort ( Figure 1 ). In contrast, the model inferred from the highly multiplexed, aptamer-based proteomic data set
). Platform performance was also assessed by including only the proteins shared (n ¼ 52) by both platforms. Contrasting with the antibody-based platform, the reduced aptamer-based platform did pass validation in the independent cohort (P ¼ 1.7 Â 10 e3 ). Results suggest that the aptamerbased platform outperformed the antibody-based platform, at least in studied context. Consequently, more indepth analyses were performed only for the full aptamer-based proteomic data set.
Proteomic model
Plasma proteins formed a correlation network that highlights the interconnectivity of the proteomic changes over the course of pregnancy (Supplemental Figure 1, Appendix B) . The model best predicting GA at the time of sampling consisted of 74 proteins derived from the 1300 proteins that built the entire correlation network (Supplemental Table 1 , Appendix B).
Reduced proteomic model
Piecewise regression analysis revealed that only 8 proteins were required to predict GA with similar power as the full model (Figure 2A) . Features of the reduced model are listed in Table 2 and are projected onto the correlation network in Figure 2B . The high predictive power of the reduced model is reflected by the correlation coefficients between model values and GA.
Correlation coefficients derived in the training cohort were the same for the full ( Figure 3A ; R ¼ 0.97) and the reduced model ( Figure 3B ) and accounted for 94% of observed variance. Correlation coefficients derived in the validation cohort were similar for the full (R ¼ 0.94) and the reduced model A proteomic model containing eight proteins predicts gestational age A, Eight plasma proteins sufficed to predict gestational age without losing predictive power. The dashed red lines depict the regression fit and highlight the break point associated with the loss of predictive power. B, The 8 proteins are projected onto the correlation network and are highlighted as red dots. Abundance of all 8 proteins increased during pregnancy and was positively correlated with gestational age. The dot size is proportional to the P value. Proteins are listed by their gene identification and are ranked from the highest to the lowest absolute correlation coefficient within modules containing proteomic changes with the highest correlations. Full name, UniProt ID, and statistical attributes of the 8 proteins are listed in Table 2 . These results suggest that changes in JAK-STAT signaling are important biological characteristics of pregnancy. Ten of the 74 plasma proteins included in the full proteomic model were linked to JAK-STAT signaling (Table 3) .
GO enrichment analysis
Link between proteins associated with JAK-STAT signaling and immune features predicting GA
The top-ranked endogenous signaling change in immune cells predicting GA was STAT5 signaling in naïve CD4 þ T cells. 19 Endogenous signaling events are particularly informative because they reflect the in vivo functional behavior of immune cells. GO analysis revealed significant enrichment of 10 proteins associated with JAK-STAT1, -STAT3, 
FIGURE 3
Predictive power of the full and reduced proteomic models ajog.org
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and -STAT5 signaling in various cell types (Table 3) . 28, 29 A correlation analysis was therefore performed between STAT1, STAT3, and STAT5 signaling activities in naïve CD4 þ T cells and abundance of the 10 plasma proteins. Correlation analysis was also performed between STAT1, STAT3, and STAT5 signaling activity in all immune cells and abundance of the 10 plasma proteins (controls). Significant correlations were identified between several but not all plasma proteins and STAT5 signaling in naïve CD4 þ T cells ( Figure 5A ). The strongest correlation was observed for chorionic somatomammotropin and STAT5, which accounted for 36% of observed variance ( Figure 5B ).
Comment
A highly multiplexed platform revealed precisely timed changes of the plasma proteome over the course of pregnancy. A model including 8 proteins revealed a proteomic clock that strongly predicted GA at the time of sampling in pregnancies delivering at term. The exciting promise of such a clock is that deviations from its regular chronological profile might assist in the early diagnoses of pregnancyrelated pathologies and point to relevant underlying pathophysiology. Observed results support the utility of using a highly multiplexed proteomic platform to derive disease-specific signatures.
A strength of our study is the derivation and validation of a predictive model using a multivariate approach. A recent study using the highly multiplexed platform by SomaLogic Inc identified 112 plasma proteins that significantly changed in abundance during pregnancy. Thirty-one of these 112 proteins were included in our full model containing 74 proteins. This partial overlap is not surprising because the previous study did not examine the predictive power of observed changes. However, derivation of a predictive model is a sensible probabilistic approach to select a limited number of proteins for further examination and discussion. It seems reasonable to propose that the 8 proteins contained in our final model likely track important physiological adaptations during pregnancy.
Another strength of our study is the linkage between observed predictive proteomic changes and immunological changes previously reported for the same patient cohort. 19 This analysis led to the novel hypothesis that CSH1/2 may critically regulate T-cell function via the STAT5 signaling pathway during pregnancy. At this point, we can only speculate as to how CSH1/2 may regulate STAT5 in T cells. However, CSH1/2 bind to the prolactin receptor in a zincdependent manner, while they do not bind to the growth hormone receptor. 30 T cells express the prolactin receptor, which signals through STAT5. 31, 32 Our study has several limitations. The relatively small size limits its generalizability. It will be important to test the generalizability of our findings and examine variations of the proteomic model possibly associated with ethnic, racial, and socioeconomic differences. The statistical stringency and the independent validation of our results provide strong support for the conduct of such studies. By design, most blood samples were collected between gestational weeks 10 and 30, with a sampling gap between gestational weeks 19 and 24. There remains some uncertainty about the predictive power of our model for samples collected outside studied sampling periods. Our model emphasized chronological proteomic changes over the course of pregnancy. It is unlikely that all disruptive proteomic patterns characterizing pregnancy-related pathologies will become manifest as deviations from this chronological profile. However, our approach can be applied to detect important proteomic patterns that do not follow a tight chronological pattern. Finally, current advances in multiplex FIGURE 4 Individual plasma profiles of the 3 top-ranked proteins A, Solid black lines depict individual plasma profiles in RFUs for the top 3 proteins included in the reduced and final model predicting gestational age in the training cohort. The 3 proteins were GPC3, CSH1/2, and GRNs. Sampling time points are indicated by black dots. The red lines and red-shaded area indicate plasma profiles for the population and corresponding 95% confidence intervals. The gray-shaded areas indicate time intervals for which plasma profiles are uncertain because no samples were collected during these periods. PP indicates the postpartum period. B, Equivalent results are displayed for the validation cohort. Importantly, derivation of splines (solid black lines) served only visualization purposes and was not part of model development and statistical analysis. technologies will allow assaying several thousand proteins in the near future, which will further reduce biases in prediction.
Although our proteomic model possesses remarkable predictive power, inspection of Figure 3 suggests lower accuracy compared with ultrasound measurements for predicting GA. Ultrasound measurements during the first trimester establish GA with an estimated accuracy to within 5e7 days.
22, [33] [34] [35] We derived our model in a relatively small cohort, and its refinement in a larger cohort will likely increase its accuracy. It seems plausible that such a proteomic model can complement current methods used to determine GA. For example, the antenatal diagnosis of IUGR and its differentiation from constitutional smallness remains a clinical challenge. 36, 37 Divergent or convergent tracking of GA with ultrasound and proteomic metrics may facilitate such differentiation.
Early recognition of pregnancyrelated pathologies is an essential component of maternity care and significantly decreases the incidence of adverse fetal outcomes. 38 Novel metrics including plasma proteins to improve such efforts have been called for. 39 For example, pregnancy-associated plasma protein A (PAPPA) has received significant attention as a biomarker of IUGR and other pregnancy-related pathologies. [40] [41] [42] [43] [44] While plasma levels of PAPPA are associated with IUGR, they lack sufficient predictive power to be of broader clinical utility when assessed in isolation. 8, [45] [46] [47] [48] [49] In fact, poor predictive power is a common feature of individually studied plasma proteins and drives current efforts toward the combined use of several biomarkers to improve risk prediction. [8] [9] [10] [11] 50 Our results echo the ajog.org OBSTETRICS Original Research merit of such efforts because 8 plasma proteins were required to predict GA without compromising power.
Notably, although measured, PAPPA was not a feature in our final model containing 8 proteins. Conversely, the 3 top-ranked proteins glypican 3 (GPC3), CSH1/2, and granulins (GRNs) have sparsely been studied as biomarkers of pregnancy-related pathologies. [51] [52] [53] [54] [55] [56] Their tight chronological profile in individual women over the course of pregnancy and their synthesis in placental tissue provide a strong rationale for further examining their utility as biomarkers. 57, 58 GPC3 is a member of the cell surface heparan sulfate proteoglycan family and regulates cell growth by facilitating Wnt and suppressing Hedgehog signaling. [59] [60] [61] GPC3 is also cleaved from the cell surface and then acts as a competitive inhibitor of Wnt. 62 Loss of function of the human GPC3 gene results in the Simpson-Golabi-Behmel syndrome, a condition characterized by severe malformations, which reflects the importance of GPC3 for normal morphogenesis. A single study reported a decreased placental GPC3 expression in women with preeclampsia. 63 GRNs exert broad biological activities including growth factor-like and immune-modulating effects. [64] [65] [66] [67] [68] [69] [70] GRNs are cleaved from progranulin, a secreted glycoprotein that is widely expressed in epithelia, immune cells, the central nervous system, and solid organs including the placenta. 58, 71 Loss-of-function mutations have been associated with a dysregulated and proinflammatory immune responses. 72 Two recent studies reported increased placental expression of GRNs in women with preeclampsia and IUGR and increased serum GRNs in women with late-onset preeclampsia. 51, 73 CSH1/2 are placenta-specific secreted proteins that belong to the growth hormone/prolactin gene family. 74 CSH1/2 are critical regulators of maternal and fetal metabolism and fetal growth and development.
75 CSH1/2 expression is reduced in the placenta of women with small-for-gestational-age newborns. 76 A recent study in sheep demonstrated a causal role of CSH1/2 for normal placental and fetal growth and development. 77 Of the 5 remaining proteins contained in the final model, colony-stimulating factor 1 receptor (CSF1R), RET, and polymeric immunoglobulin receptor (PIGR) are cell surface receptors that occur in soluble form when shed from the cell surface. Whether soluble CSF1R, RET, and PIGR exert physiological functions is not clear. One can speculate that increased plasma concentrations may reflect increased cell surface expression and shedding. CSF1 regulates the production, differentiation, and function of macrophages. 78 PIGR is an Fc receptor that facilitates the secretion of the soluble polymeric isoforms of immunoglobulin A. 79 RET is a tyrosine kinase receptor that binds neurotrophic factors and regulates the development and maturation of the nervous system and neuroendocrine cell types in various tissues. 80 Finally, alphafetoprotein is secreted by the fetal liver and crosses the placenta into the maternal blood, while prolactin is a placental hormone that exerts well-defined physiological functions. n
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